The table below shows CONMED Corp's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$170.69M
$166.97M
$125.35M
$33.37M
$111.77M
$64.53M
Capital expenditure
$19.81M
$13.08M
$19.03M
$21.79M
$14.87M
$13.01M
Investing cash flow
-$20.96M
-$13.08M
-$20.03M
-$249.53M
-$14.87M
-$13.64M
Dividends paid
$24.75M
$24.65M
$24.50M
$23.96M
$23.26M
CNMD operating cash flow (10-K history)
CONMED Corp reported operating cash flow of $170.69M for fiscal year 2025. That is up 2.2% from $166.97M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $39.88M (FY 2016) to $170.69M. Figures come from the company's audited annual reports as filed with the SEC.
